Hayashi N, Hayama K, Takahashi K, Kurokawa I, et al. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in Japan. J Dermatol 2023;50:1034-1044.
PMID: 37264993